PET/CT Interpretative Pitfalls in Thoracic Malignancies

被引：6

作者：

Shroff, Girish S. ^{[1
]}

Sabloff, Bradley S. ^{[1
]}

Truong, Mylene T. ^{[1
]}

Carter, Brett W. ^{[1
]}

Viswanathan, Chitra ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, 1515 Holcombe Blvd,Unit 1478, Houston, TX 77030 USA

来源：

SEMINARS IN ULTRASOUND CT AND MRI | 2018年 / 39卷 / 03期

关键词：

POSITRON-EMISSION-TOMOGRAPHY; CELL LUNG-CANCER; PULMONARY NODULES; FDG UPTAKE; ESOPHAGEAL-CARCINOMA; ADIPOSE-TISSUE; CT; IMAGES; ARTIFACTS; ABNORMALITIES;

D O I：

10.1053/j.sult.2018.02.007

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Applications of positron emission tomography/computed tomography (PET/CT) in the thorax include the evaluation of solitary pulmonary nodules, staging and restaging of oncologic patients, assessment of therapeutic response, and detection of residual or recurrent disease. Accurate interpretation of PET/CT requires knowledge of the physiological distribution of [18 F]-fluoro-2-deoxy-D-glucose, as well as artifacts and quantitative errors due to the use of CT for attenuation correction of the PET scan. Potential pitfalls include malignancies that are PET negative and benign conditions that are PET positive. Awareness of these artifacts and potential pitfalls is important in preventing misinterpretation that can alter patient management. (C) 2018 Elsevier Inc. All rights reserved.

引用

页码：282 / 288

页数：7

共 29 条

[1] False-positive FDG positron emission tomography uptake in nonmalignant chest abnormalities [J].